Carcinoembryonic antigen-related cell adhesion molecule 5 (653-667)

Carcinoembryonic antigen-related cell adhesion molecule 5 (653-667) is a synthetic peptide fragment derived from the CEACAM5 protein, which plays a pivotal role in cell adhesion, intercellular communication, and signal transduction within various tissue types. As a member of the immunoglobulin superfamily, CEACAM5 is widely recognized for its involvement in modulating cell-cell interactions, particularly in epithelial tissues and within the context of tumor biology. The 653-667 region represents a specific amino acid sequence that is often targeted in studies investigating the structural and functional determinants of CEACAM5-mediated processes. Researchers utilize this peptide to gain detailed insights into molecular recognition events, protein-protein interactions, and the broader implications of cell adhesion molecules in physiological and pathological contexts.

Epitope mapping: The 653-667 peptide segment is frequently employed in epitope mapping experiments to identify and characterize antibody binding sites on the CEACAM5 protein. By synthesizing and utilizing this defined sequence, investigators can dissect the specificity of monoclonal or polyclonal antibodies developed against CEACAM5, thereby facilitating the development of more precise immunodetection tools. Such studies are crucial for understanding immune recognition and for optimizing reagents used in immunoassays and diagnostic platforms.

Protein-protein interaction studies: Researchers leverage the defined structure of the 653-667 peptide to probe the molecular basis of CEACAM5-mediated cell adhesion and signaling. In vitro assays utilizing this fragment can elucidate how specific protein domains interact with cellular partners, such as integrins or other adhesion molecules. These insights inform the broader understanding of tissue organization, cellular communication, and the mechanisms underlying cellular aggregation and migration.

Peptide-based assay development: The unique sequence of this CEACAM5-derived peptide supports the design and optimization of peptide-based assays for the detection and quantification of CEACAM5 or its interacting partners. Incorporating the 653-667 fragment into enzyme-linked immunosorbent assays (ELISAs), biosensors, or bead-based multiplex platforms enables sensitive and specific measurement of target molecules in research samples. Such assays are vital in both basic and translational research settings, where accurate biomolecular quantification is essential.

Structural and functional analysis: The synthetic 653-667 peptide provides a tractable model for high-resolution studies of CEACAM5's structural motifs and functional domains. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism, or crystallography can employ this peptide to investigate secondary structure propensities, conformational dynamics, and stability. These analyses contribute to a deeper understanding of how discrete sequence elements influence the overall architecture and activity of cell adhesion molecules.

Immunogenicity and peptide vaccine research: The defined amino acid sequence of the 653-667 region makes it suitable for studies focused on peptide immunogenicity and the development of experimental peptide vaccines. By evaluating the immune response elicited by this fragment in vitro or in preclinical models, researchers can assess its potential as an immunogen or as a component in vaccine formulation research. Such investigations inform the rational design of peptide-based immunological tools and advance knowledge of antigenic determinants within the CEACAM5 protein family.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

4. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients